SCHEMBL16763232

SCHEMBL16763232

COc1c(-c2ccccc2)sc2cc[nH]c12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 2/20 0.35
PDE4B Q07343 2/20 0.35
PDE4C Q08493 2/20 0.35
PDE4D Q08499 2/20 0.35
ALDH1A1 P00352 5/20 0.33
ALOX5 P09917 2/20 0.33
POLB P06746 1/20 0.33
GRM6 O15303 1/20 0.33
GRM5 P41594 1/20 0.33
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33
TUBA3C P0DPH7 1/20 0.33
TUBA1B P68363 1/20 0.33
TUBA4A P68366 1/20 0.33
TUBB4B P68371 1/20 0.33
TUBB3 Q13509 1/20 0.33
TUBB2A Q13885 1/20 0.33
TUBB8 Q3ZCM7 1/20 0.33
TUBA3E Q6PEY2 1/20 0.33
TUBA1A Q71U36 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5036679 0.73
SCHEMBL10691956 0.65 KDM4E (0.39) ALDH1A1POLBTUBB4ATUBBTUBA3C
SCHEMBL28049111 0.61 GRM6 (0.36) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL20684280 0.61 L3MBTL1 (0.46) ALDH1A1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL10844900 0.60 CA12 (0.44) PDE4BALDH1A1TUBB4ATUBBTUBA3C
SCHEMBL11331212 0.60 KDM4E (0.40) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL12181771 0.59 PDE4B (0.71) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL18775276 0.59 PDE4B (0.44) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL26173373 0.59 MAPT (0.44) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL21724837 0.58 NOTUM (0.41) ALDH1A1ALOX5POLBGRM6GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9611281-B2 BODIPY derivatives and methods of synthesis and use thereof THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) 2017-04-04 US disclosed
US-20150158888-A1 BODIPY Derivatives and Methods of Synthesis and Use Thereof THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA 2015-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150158888-A1 BODIPY Derivatives and Methods of Synthesis and Use Thereof FDPS, FDFT1, BCR PDE4A 4028/4885PDE4B 3598/4885PDE4C 4473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.